AXSOME THERAPEUTICS INC. - COMMON STOCK
73.68
09-五月-24 15:59:55
15 分钟延时
股票
-2.00
-2.64%
今日范围
73.65 - 76.56
ISIN
N/A
来源
NASDAQ
-
Axsome Therapeutics to Report First Quarter 2023 Financial Results on May 8
13 4月 2023 07:00:34 条件 Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at Cowen’s 43rd Annual Health Care Conference
01 3月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
27 2月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
22 2月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at the SVB Securities Global Biopharma Conference
07 2月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
Axsome Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on February 27
31 1月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
07 12月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
28 11月 2022 06:35:00 条件 Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at the 5th Annual Evercore ISI HealthCONx Conference
23 11月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at the Guggenheim 4th Annual Immunology and Neurology Conference
09 11月 2022 07:00:02 条件 Nasdaq GlobeNewswire
-
Axsome Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
07 11月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
Axsome Therapeutics to Ring the NASDAQ Stock Market Opening Bell Today
27 10月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
Axsome Therapeutics to Report Third Quarter 2022 Financial Results on November 7, 2022
21 10月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
20 10月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
Axsome Therapeutics Voices its Commitment to Mental Health on World Mental Health Day 2022
10 10月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
Axsome Therapeutics Announces Plans to Resubmit AXS-07 NDA Based on Successful FDA Type A Meeting
29 9月 2022 07:28:00 条件 Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at the Ladenburg Thalmann Healthcare Conference
21 9月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at the Cowen 2nd Annual Novel Mechanisms in Neuropsychiatry Summit
14 9月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
Axsome Therapeutics Initiates ADVANCE-2 Phase 3 Trial of AXS-05 in Alzheimer’s Disease Agitation
08 9月 2022 07:00:01 条件 Nasdaq GlobeNewswire